Wang Sophie Shih-Yüng, Machetanz Kathrin, Ebner Florian, Naros Georgios, Tatagiba Marcos
Department of Neurosurgery and Neurotechnology, Eberhard Karls University Tübingen, Tübingen, Germany.
Department of Neurosurgery, Alfried Krupp Hospital, Essen, Germany.
Front Oncol. 2023 Jun 5;13:1153698. doi: 10.3389/fonc.2023.1153698. eCollection 2023.
Despite the ongoing debate on the risk-benefit ratio of vestibular schwannoma (VS) treatment options, watchful observation and radiation are usually favored in the elderly (>65 years). If surgery is inevitable, a multimodal approach after deliberate subtotal resection has been described as a valid option. The relationship between the extent of resection (EOR) of surgical and functional outcomes and recurrence-free survival (RFS) remains unclear. This present study aims to evaluate the functional outcome and RFS of the elderly in relation to the EOR.
This matched cohort study analyzed all consecutive elderly VS patients treated at a tertiary referral center since 2005. A separate cohort (<65 years) served as a matched control group (young). Clinical status was assessed by the Charlson Comorbidity Index (CCI), the Karnofsky Performance (KPS), and the Gardner and Robertson (GR) and House & Brackmann (H&B) scales. RFS was evaluated by Kaplan-Meier analysis using contrast-enhanced magnetic resonance imaging to identify tumor recurrence.
Among 2,191 patients, 296 (14%) patients were classified as elderly, of whom 133 (41%) were treated surgically. The elderly were characterized by a higher preoperative morbidity and worse gait uncertainty. Postoperative mortality (0.8% and 1%), morbidity (13% and 14%), and the functional outcome (G&R, H&B, and KPS) did not differ between the elderly and the young. There was a significant benefit in regard to the preoperative imbalance. Gross total resection (GTR) was accomplished in 74% of all cases. Lower grades of the EOR (subtotal and decompressive surgery) raised the incidence of recurrence significantly. Mean time to recurrence in the ELDERLY was 67.33 ± 42.02 months and 63.2 ± 70.98 months in the .
Surgical VS treatment aiming for complete tumor resection is feasible and safe, even in advanced age. A higher EOR is not associated with cranial nerve deterioration in the elderly compared to the young. In contrast, the EOR determines RFS and the incidence of recurrence/progression in both study cohorts. If surgery is indicated in the elderly, GTR can be intended safely, and if only subtotal resection is achieved, further adjuvant therapy, e.g., radiotherapy, should be discussed in the elderly, as the incidence of recurrence is not significantly lower compared to the young.
尽管关于前庭神经鞘瘤(VS)治疗方案的风险效益比仍存在争议,但对于老年患者(>65岁),通常倾向于密切观察和放疗。如果手术不可避免,在有意进行次全切除术后采用多模式方法已被描述为一种有效的选择。手术切除范围(EOR)与功能结果及无复发生存期(RFS)之间的关系仍不清楚。本研究旨在评估老年患者的功能结果和RFS与EOR的关系。
这项匹配队列研究分析了自2005年以来在一家三级转诊中心接受治疗的所有连续老年VS患者。另一个队列(<65岁)作为匹配对照组(年轻组)。通过Charlson合并症指数(CCI)、卡诺夫斯基表现状态评分(KPS)以及Gardner和Robertson(GR)量表和House & Brackmann(H&B)量表评估临床状态。使用对比增强磁共振成像来识别肿瘤复发,通过Kaplan-Meier分析评估RFS。
在2191例患者中,296例(14%)患者被归类为老年患者,其中133例(41%)接受了手术治疗。老年患者的特点是术前发病率较高且步态不确定性较差。老年组和年轻组的术后死亡率(0.8%和1%)、发病率(13%和14%)以及功能结果(G&R、H&B和KPS)并无差异。术前平衡方面有显著益处。所有病例中有74%实现了全切除(GTR)。较低级别的EOR(次全切除和减压手术)显著提高了复发率。老年组的平均复发时间为67.33±42.02个月,年轻组为63.2±70.98个月。
即使在高龄患者中,旨在实现肿瘤完全切除的手术治疗VS也是可行且安全的。与年轻患者相比,老年患者中较高的EOR与脑神经恶化无关。相反,EOR决定了两个研究队列中的RFS以及复发/进展的发生率。如果老年患者需要手术,可安全地进行GTR,如果仅实现了次全切除,则应在老年患者中讨论进一步的辅助治疗,例如放疗,因为与年轻患者相比,其复发率并没有显著降低。